行情

GENE

GENE

基因技术
NASDAQ

实时行情|Nasdaq Last Sale

1.630
0.000
0.00%
盘前: 1.750 +0.12 +7.36% 09:19 04/02 EDT
开盘
--
昨收
1.970
最高
--
最低
--
成交量
--
成交额
--
52周最高
6.32
52周最低
1.408
市值
1,103.82万
市盈率(TTM)
-3.5190
分时
5日
1月
3月
1年
5年

EPS

GENE 新闻

更多
  • Genetic Technologies Announces $1.8 Million Registered Direct Offering
  • GlobeNewswire · 19小时前
  • Genetic Technologies Prices ~1.029M ADS Offering At $1.75/ADS
  • Benzinga · 20小时前
  • CRNC, APRN, ARNC and VVUS among midday movers
  • Seeking Alpha - Article · 20小时前
  • Genetic Tech up 23% on planned launch of consumer-initiated testing
  • Seeking Alpha - Article · 22小时前

所属板块

医疗设施与服务
-3.84%
医疗保健提供商与服务
-4.36%

热门股票

代码
价格
涨跌幅

GENE 简况

Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The Company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/gynecologists (OBGYNs) and breast cancer risk assessment specialists, such as breast surgeons. The Company operates in Australia, the United States and Switzerland. The Company's subsidiaries include Genetic Technologies Corporation Pty. Ltd. and Phenogen Sciences Inc. Genetic Technologies Corporation Pty. Ltd. is engaged in genetic testing. The Company has launched the BREVAGen test across the United States through Phenogen Sciences Inc.
展开

微牛提供Genetic Technologies Limited (ADR)(NASDAQ-GENE)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的GENE股票新闻,以帮助您做出投资决策。